Cross-talk between Bcr-abl and the Thioredoxin System in Chronic Myeloid Leukaemia: Implications for CML TreatmentErin Clapper, Kathryn F. Tonissen|Antioxidants|2020Cited by 17
The Effect of BCR-ABL Specific Tyrosine Kinase Inhibitors on the Thioredoxin System in Chronic Myeloid LeukemiaErin Clapper, Kathryn F. Tonissen|Hemato|2021Cited by 0